- Home
- SLGL vs OPP Comparison
SLGL vs OPP Comparison
Compare SLGL & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLGL | OPP |
|---|---|---|
| Founded | 1997 | 2010 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.9M | 190.4M |
| IPO Year | 2016 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SLGL | OPP |
|---|---|---|
| Price | $70.75 | $6.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $152.50 | N/A |
| AVG Volume (30 Days) | 37.3K | ★ 113.4K |
| Earning Date | 11-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $111.86 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.50 | $6.82 |
| 52 Week High | $97.97 | $8.59 |
Technical Indicators
Market Signals| Indicator | SLGL | OPP |
|---|---|---|
| Relative Strength Index (RSI) | 60.11 | 28.98 |
| Support Level | $68.64 | N/A |
| Resistance Level | $75.00 | $7.95 |
| Average True Range (ATR) | 3.39 | 0.11 |
| MACD | 1.86 | -0.01 |
| Stochastic Oscillator | 83.22 | 25.00 |
Price Performance
Historical ComparisonAbout SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.